Matches in Nanopublications for { ?s ?p "Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.